Institute for Clinical and Economic Review Publishes Final Evidence Report on Therapies for IgA Nephropathy
March 31, 2026
March 31, 2026
BOSTON, Massachusetts, March 31 (TNSrpt) -- The Institute for Clinical and Economic Review issued the following news release:
* * *
Institute for Clinical and Economic Review Publishes Final Evidence Report on Therapies for IgA Nephropathy
-- Independent appraisal committee found a net health benefit for sibeprenlimab, atacicept, and Nefecon --
*
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence . . .
* * *
Institute for Clinical and Economic Review Publishes Final Evidence Report on Therapies for IgA Nephropathy
-- Independent appraisal committee found a net health benefit for sibeprenlimab, atacicept, and Nefecon --
*
The Institute for Clinical and Economic Review (ICER) today released a Final Evidence . . .
